Skip to search.
 STI Up0.30%

Keryx Biopharmaceuticals Inc. (KERX)

-NCM

8.05 22 May 04:00 SGT

Add to Portfolio
Cash FlowGet Cash Flow for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 31, 2013Dec 31, 2012Sep 30, 2012Jun 30, 2012
Net Income (2,055) (6,628) (5,475) (1,504)
Operating Activities, Cash Flows Provided By or Used In
Depreciation10  8  8  9  
Adjustments To Net Income581  538  545  (2,201)
Changes In Accounts Receivables -   -  38  29  
Changes In Liabilities605  388  (1,607)(467)
Changes In Inventories -   -   -   -  
Changes In Other Operating Activities(1,279)128  (357)334  
Total Cash Flow From Operating Activities (2,138) (5,566) (6,848) (3,800)
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures(45)(5)(16)(1)
Investments -   -  6,012  3,201  
Other Cash flows from Investing Activities -   -   -   -  
Total Cash Flows From Investing Activities (45) (5) 5,996   3,200  
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid -   -   -   -  
Sale Purchase of Stock74,849   -   -   -  
Net Borrowings -   -   -   -  
Other Cash Flows from Financing Activities -   -   -   -  
Total Cash Flows From Financing Activities 74,849   -   -   -  
Effect Of Exchange Rate Changes -   -   -   -  
Change In Cash and Cash Equivalents 72,666   (5,571) (852) (600)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.